Bristol Myers Squibb to buy cancer drugmaker Mirati Therapeutics in up to $5.8B deal - Fox Business
foxbusiness.comSubmitted by foxbusiness4472 in business
Bristol Myers Squibb will buy Mirati Therapeutics in a deal worth up to $5.8 billion, or $58 per share, the biopharmaceutical company announced Sunday.